Setmelanotide

( DrugBank: Setmelanotide / KEGG DRUG: Setmelanotide, Setmelanotide acetate )

---

5 diseases

134. 中隔視神経形成異常症／ドモルシア症候群

---

臨床試験数 : 3 / 薬物数 : 3 - (DrugBank : 1) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 3 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

193. プラダー・ウィリ症候群

---

臨床試験数 : 140 / 薬物数 : 137 - (DrugBank : 26) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 64 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

202. スミス・マギニス症候群

---

臨床試験数 : 9 / 薬物数 : 10 - (DrugBank : 3) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 4 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

236. 偽性副甲状腺機能低下症

---

臨床試験数 : 6 / 薬物数 : 5 - (DrugBank : 3) / 標的遺伝子数 : 20 - 標的パスウェイ数 : 28 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

265. 脂肪萎縮症

---

臨床試験数 : 133 / 薬物数 : 176 - (DrugBank : 58) / 標的遺伝子数 : 30 - 標的パスウェイ数 : 102 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries